)
Visual
earnings real time
PW Medtech Group
PW Medtech Group (1358) investor relations material
PW Medtech Group H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary29 Aug, 2025
Executive summary
Revenue rose 22.4% year-over-year to RMB414.4 million, driven by strong Blood Purification Business growth and the debut of Regenerative Medical Biomaterials revenue.
Gross profit increased 13.4% to RMB212.8 million, with gross margin at 51.3%, down from 55.4% due to pricing pressure and product mix.
Profit attributable to owners declined 6.0% to RMB66.0 million, mainly due to higher expenses and lower finance income.
Adjusted profit attributable to owners (non-HKFRS) rose 10.9% to RMB83.4 million, reflecting adjustments for share-based compensation, spin-off costs, and amortization.
Interim dividend of HK4.4 cents per share declared.
Financial highlights
Blood Purification Business revenue surged 44.5% year-over-year to RMB297.4 million, now 71.8% of total revenue.
Infusion Set Business revenue fell 14.5% to RMB113.4 million, impacted by volume-based procurement and soft demand.
Regenerative Medical Biomaterials Business recorded RMB3.5 million in its first revenue contribution.
Operating profit dropped 5.1% to RMB80.2 million; net finance income fell 17.5% to RMB22.9 million.
Cash and cash equivalents stood at RMB1,693.3 million as of June 30, 2025.
Outlook and guidance
Focus remains on expanding production, product portfolio, and international markets, especially for blood purification products.
Continued R&D investment and product registration efforts across all segments.
Management expects Regenerative Medical Biomaterials to become a new growth engine.
Ongoing response to centralized procurement and market reforms to maintain competitiveness.
Management sees opportunities in domestic substitution and international expansion despite procurement challenges.
VBP impact on Blood Purification margins?
Why Regenerative Medical G&A surge?
Sichuan Ruijian Medical spin-off update?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- CSIG
IPO seeks $922M+ for tech-driven capital markets platform; strong growth, high dilution, controlled structure. - SVEA
Net profit rose 41% to 10,910 MSEK in 2025, with a proposed 1,338 MSEK dividend. - SWK
Gross margin and net income rose, with CAM divestiture set to reduce debt and boost 2026 outlook. - TOM2
Record Automotive backlog and margin gains offset a 3% revenue decline in 2025. - CMBT
Q1 profit, Golden Ocean merger, and decarbonization drive strong outlook. - CBT
Adjusted EPS down 13% to $1.53 as Battery Materials growth offset Reinforcement Materials decline. - ADVENZYMES
Q3 FY26 revenue up 2% YoY, PAT up 11%, with wind power SPV investment approved. - SIMO
Q4 2025 revenue and margins surged on SSD, eMMC/UFS, and automotive growth; 2026 outlook strong. - FSV
Annual revenue up 5% to $5.50B; Adjusted EBITDA and EPS both saw double-digit growth. - QLINEA
Over 400% revenue growth in 2025, with US expansion and breakeven targeted for 2027.
Next PW Medtech Group earnings date
H2 202527 Mar, 2026
PW Medtech Group
Next PW Medtech Group earnings date
H2 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
PW Medtech Group Limited is a medical device company that specializes in the research, development, manufacture, and distribution of healthcare products primarily for use in China. The company’s product portfolio focuses on infusion sets, wound care, and regenerative biomaterial solutions, serving hospitals and healthcare providers in a range of therapeutic areas. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage